XFOR
X4 Pharmaceuticals Inc
2.90$
-3.8%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | |
| – | – | – | 2.9% | 22.4% | 41.0% | – | – | – | 31.2% | 17.8% | |
| – | – | – | -2.9% | -22.4% | 100.0% | – | – | – | 68.8% | 82.2% | |
| – | – | – | 581.3% | 1,005.4% | 1,397.7% | – | – | – | 3,192.9% | 205.7% | |
| – | – | – | 525.9% | 588.0% | 698.1% | – | – | – | 2,405.9% | 123.9% | |
| – | – | – | 828.1% | 1,537.7% | 2,095.8% | – | – | – | 1,492.4% | 329.6% | |
| – | – | – | -831.0% | -1,560.1% | -1,995.8% | – | – | – | -1,423.6% | -247.4% | |
| – | – | – | 20.6% | 71.6% | 89.6% | – | – | – | 342.9% | 25.3% | |
| – | – | – | -951.0% | -1,760.2% | -2,066.1% | – | – | – | -1,452.5% | -225.4% | |
| – | – | – | 111.5% | 126.6% | 4.9% | – | – | – | 12.1% | 0.1% | |
| – | – | – | -951.0% | -1,760.2% | -2,071.0% | – | – | – | -1,464.6% | -225.6% | |
| – | – | – | -828.1% | -1,537.7% | -1,984.1% | – | – | – | -1,078.5% | -196.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.